Two Cases of Mycobacterium shinjukuense Pulmonary Disease With a Long-Term Response to Treatment With Clarithromycin, Rifampicin, and Ethambutol
Takeshi Imakura(Tokushima Prefectural Central Hospital), Takashi Haku(Tokushima Prefectural Central Hospital), Naoya Murakami(Tokushima University Hospital), Hitomi Kagawa(Tokushima Prefectural Central Hospital), Soji Kakiuchi(Tokushima Prefectural Central Hospital)
Cited by 1
Related Papers
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)
|Human Molecular Genetics|2004|175
Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice.
|PubMed|2003|114
Retreatment of Lung Adenocarcinoma Patients With Gefitinib Who Had Experienced Favorable Results From Their Initial Treatment With This Selective Epidermal Growth Factor Receptor Inhibitor: A Report of Three Cases
|Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics|2005|97